TAGLIAFICO, Enrico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.056
EU - Europa 9.461
AS - Asia 3.640
SA - Sud America 53
AF - Africa 34
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 23
Totale 31.300
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.970
GB - Regno Unito 3.182
IT - Italia 2.095
SE - Svezia 1.233
SG - Singapore 1.087
CN - Cina 1.018
DE - Germania 787
HK - Hong Kong 627
TR - Turchia 370
UA - Ucraina 355
FR - Francia 329
FI - Finlandia 314
RU - Federazione Russa 254
IE - Irlanda 210
BG - Bulgaria 185
ID - Indonesia 178
SI - Slovenia 155
IN - India 116
CA - Canada 73
BE - Belgio 68
VN - Vietnam 60
CZ - Repubblica Ceca 52
NL - Olanda 49
PL - Polonia 33
LT - Lituania 32
BR - Brasile 29
AU - Australia 28
JP - Giappone 28
IR - Iran 25
MY - Malesia 25
CH - Svizzera 24
EU - Europa 19
ES - Italia 16
GR - Grecia 16
KR - Corea 16
QA - Qatar 16
RO - Romania 16
PK - Pakistan 15
TW - Taiwan 14
NO - Norvegia 13
CL - Cile 11
IQ - Iraq 9
PT - Portogallo 8
MX - Messico 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
EG - Egitto 6
HU - Ungheria 6
IL - Israele 6
KE - Kenya 6
MA - Marocco 5
NZ - Nuova Zelanda 5
RS - Serbia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
BD - Bangladesh 4
NG - Nigeria 4
PH - Filippine 4
TH - Thailandia 4
BH - Bahrain 3
DK - Danimarca 3
GH - Ghana 3
IS - Islanda 3
LV - Lettonia 3
TN - Tunisia 3
AR - Argentina 2
CI - Costa d'Avorio 2
JM - Giamaica 2
LK - Sri Lanka 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
PA - Panama 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
ZA - Sudafrica 2
AL - Albania 1
AZ - Azerbaigian 1
BJ - Benin 1
BO - Bolivia 1
BZ - Belize 1
DZ - Algeria 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GL - Groenlandia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
PE - Perù 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 31.300
Salva come PNG Salva come JPEG
Città #
Southend 2.721
Fairfield 2.414
Santa Clara 2.261
Chandler 1.515
Woodbridge 1.469
Ashburn 1.211
Houston 1.073
Seattle 866
Singapore 823
Ann Arbor 806
Nyköping 775
Cambridge 735
Wilmington 713
Jacksonville 684
Dearborn 620
Hong Kong 611
Modena 424
Beijing 281
San Diego 259
Izmir 228
Dublin 203
Helsinki 194
Princeton 191
Sofia 185
New York 181
Jakarta 177
Eugene 138
Milan 125
Fremont 112
London 105
Shanghai 98
Moscow 94
Bremen 93
Bologna 92
Falls Church 76
Des Moines 71
Redwood City 71
Brussels 62
Rome 57
Parma 54
Dong Ket 53
Reggio Emilia 53
Boardman 47
Munich 42
Frankfurt am Main 37
Brno 36
Sant'Ilario d'Enza 33
Norwalk 31
Ottawa 31
Toronto 31
Hefei 28
Los Angeles 26
Palermo 26
Phoenix 26
Bari 24
Turin 24
Guangzhou 23
Verona 23
San Mateo 22
Florence 21
Paris 20
San Giuliano Milanese 20
Grafing 19
Hounslow 19
Kraków 18
Nanjing 18
Chicago 17
Chiswick 17
Kunming 17
Padova 17
Doha 15
Hyderabad 15
Kilburn 15
Dallas 14
Imola 14
Olomouc 14
Rimini 14
Naples 13
Monmouth Junction 12
Mountain View 12
Romainville 12
Shenyang 12
Tokyo 12
Zhengzhou 12
Athens 11
Madrid 11
Reggio Nell'emilia 11
San Francisco 11
Alexandria 10
Dongguan 10
Ferrara 10
Saint Petersburg 10
San Jose 10
Sassuolo 10
Amsterdam 9
Ankara 9
Ardabil 9
Augusta 9
Falkenstein 9
Jinan 9
Totale 24.031
Salva come PNG Salva come JPEG
Nome #
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 405
A Next Generation Sequencing amplicon-based strategy to explore Inherited Retinal Degeneration complexity 338
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 322
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients 306
Implementation of an NGS-based workflow for BRCA1 and BRCA2 mutation screening 292
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 282
c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. 268
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial 268
Transcriptional profiles in melanocytes from clinically unaffected skin distinguish the neoplastic growth pattern in patients with melanoma 265
MafB is a downstream target of the IL-10/STAT3 signaling pathway, involved in the regulation of macrophage de-activation 263
NF-YA splice variants have different roles on muscle differentiation 258
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 256
No Identical ‘‘Mesenchymal Stem Cells’’ at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels 252
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group 250
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis 249
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6 249
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis 247
Identification of a molecular signature predictive of sensitivity to differentiation induction in acute myeloid leukemia 247
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 246
Gene expression in grapevine cultivars in response to BOIS NOIR phytoplasma infection 244
Calreticulin affects hematopoietic stem/progenitor cell fate by impacting erythroid and megakaryocytic differentiation 241
Embryonic stem-derived versus somatic neural stem cells: A comparative analysis of their developmental potential and molecular phenotype 240
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 240
A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response 237
Transcriptional profiles underlying vulnerability and resilience in rats exposed to an acute unavoidable stress 237
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 236
Virally mediated MafB transduction induces the monocyte commitment of human CD34+ hematopoietic stem/progenitor cells 236
CALR mutational status identifies different disease subtypes of essential thrombocythemia showing distinct expression profiles 236
Integrative Analysis Of mRNA/miRNA Expression Profiles Identified JARID2 As a Shared Target Of Deregulated Mirnas In Primary Myelofibrosis 235
Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis 235
Amplicon-based Next Generation Sequencing: an effective approach to molecular diagnosis of Epidermolysis Bullosa 234
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 230
Amplicon-based next-generation sequencing: an effective approach for the molecular diagnosis of epidermolysis bullosa 230
Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells 229
Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations 225
Integrated analysis of microRNA and mRNA expression profiles in physiological myelopoiesis: role of hsa-mir-299-5p in CD34+ progenitor cells commitment 225
Requirement of the coiled-coil domains of p92(c-Fes) for nuclear localization in myeloid cells upon induction of differentiation 224
Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease 223
Calreticulin Ins5 and Del52 mutations impair unfolded protein and oxidative stress responses in K562 cells expressing CALR mutants 223
Polarization dictates iron handling by inflammatory and alternatively activated macrophages 222
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 221
The barley Frost resistance-H2 locus 220
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants 219
Gene expression profiles of human granulosa cells treated with bioequivalent doses of corifollitropin alfa (CFA) or recombinant human follicle-stimulating hormone (recFSH) 219
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 217
ERBB2 mutations in hormone receptor positive primary breast cancers samples and in their matched endocrine-resistant recurrences. 217
Hereditary pancreatic cancer: A retrospective single-center study of 5143 Italian families with history of BRCA-related malignancies 216
Impact of mutational status on outcomes in myelofibrosis patients treated with ruxolitinib in the COMFORT-II study 215
Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression 215
Isolation of human keratinocyte stem cells and high-throughput screening approach for their characterization 213
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 212
Microarray analysis of the chronic escape deficit model of depression: Effects of escitalopram treatment in hippocampus 211
Differentiated Neuroprogenitor Cells Incubated with Human or Canine Adenovirus, or Lentiviral Vectors Have Distinct Transcriptome Profiles 211
Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: focus on DNA repair genes 208
Gene expression profile of vitamin D3 treated HL60 cells shows an incomplete molecular phenotypic conversion to monocytes 208
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 206
Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells 205
Correlation between differentiation plasticity and mRNA expression profiling of CD34+-derived CD14- and CD14+ human normal myeloid precursors 203
Cytogenetic abnormalities and clinical features in a patient cohort affected by three or more synchronous or metachronous primitive malignancies. 203
Impact Of Prognostically Detrimental Mutations (ASXL1, EZH2, SRSF2, IDH1/2) On Outcomes In Patients With Myelofibrosis Treated With Ruxolitinib In COMFORT-II 201
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). 200
Correlation between eight-gene expression profiling and response to therapy of newly diagnosed multiple myeloma patients treated with thalidomide-dexamethasone incorporated into double autologous transplantation. 198
Transcriptional Response of Human Neurospheres to helper-dependent CAV-2 vectors involves the modulation of DNA damage response, microtubule and centromere gene groups 197
Self-Renewing Osteoprogenitors in Bone Marrow Sinusoids Can Organize a Hematopoietic microenvironment 196
Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells 196
FOXP1 and TP63 involvement in the progression of myelodysplastic syndrome with 5q- and additional cytogenetic abnormalities 196
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 195
ALTERATA REATTIVITA’ MACROFAGICA IN CORSO DI INFEZIONE MISTA DA VIRUS E FUNGHI:VALUTAZIONI FUNZIONALI, CITOFLUORIMETRICHE E DI ESPRESSIONE GENICA 193
Gene expression profiling of monocytes displaying herpes simplex virus 1 induced dysregulation of antifungal defences 193
HGM 2010 Programme / Abstract 191
Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle 190
Microarray analysis in hippocampus of rats treated with escitalopram in the chronic escape deficit model of depression 188
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 187
The kinetic status of hematopoietic stem cell subpopulations underlies a differential expression of genes involved in self-renewal, commitment, and engraftment. 185
DIAGNOSI MOLECOLARE DELLE IPERTRIGLICERIDEMIE PRIMITIVE ATTRAVERSO “NGS” (NEXT GENERATION SEQUENCING) 184
Identification of new p63 targets in human keratinocytes 182
Mutations and prognosis in primary myelofibrosis 178
Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy 178
Presence of a functional vitamin D receptor does not correlate with vitamin D3 phenotypic effects in myeloid differentiation 178
Regulatory Mrna/Microrna Networks in CD34+ Cells From Primary Myelofibrosis 175
The homeobox gene Arx is a novel positive regulator of embryonic myogenesis 175
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 175
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING MULTI-GENE PANEL 174
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 174
Usefulness and limitations of comprehensive characterization of mRNA splicing profiles in the definition of the clinical relevance of BRCA1/2 variants of uncertain significance 173
Transcriptional changes in grapevine in response to Bois Noir infection 172
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscle 171
DNA microarray to analyze adenovirus-host interactions 171
TRANSCRIPTOME ANALYSIS IN THE INTERACTION BRACHYPODIUM – PUCCINIA BRACHYPODII 170
Gene expression profiling in MDS and AML: potential and future avenues 169
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy 166
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 165
Development of an IL-6 antagonist peptide that induces apoptosis in IL-6 dependent 7TD1 cells. 165
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells 165
STRATEGIES TO PREDICT TREATMENT RESPONSE AND SELECT THERAPIES IN METASTATIC BREAST CANCER PATIENTS USING A NEXT GENERATION SEQUENCING (NGS) MULTI-GENE PANEL 162
MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response 160
Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. 158
A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines 158
Survival features of EBV-stabilized cells from centenarians: morpho-functional and transcriptomic analyses. 158
Workload measurement for molecular genetics laboratory: A survey study 158
Totale 21.504
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.033
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.645 0 0 0 0 0 757 1.035 652 466 216 274 245
2020/20214.728 453 287 305 443 415 447 330 479 277 593 359 340
2021/20224.037 264 393 391 237 179 251 210 178 401 340 670 523
2022/20234.808 547 595 503 418 516 590 112 432 656 51 194 194
2023/20243.131 117 148 220 259 487 284 387 415 91 124 202 397
2024/20254.578 311 136 226 617 1.859 1.429 0 0 0 0 0 0
Totale 31.675